Thursday, October 16, 2025 8:12:06 AM
💥 “Other research published that year found that letting people buy CBD legally significantly reduced opioid prescription rates, leading to 6.6
percent to 8.1 percent fewer opioid prescriptions.” ⬇️
💥 https://www.marijuanamoment.net/legalizing-medical-marijuana-leads-to-significant-reductions-in-opioid-prescriptions-another-study-shows/
💥 https://www.congress.gov/bill/119th-congress/house-bill/5068/cosponsors 🚀
💥 https://www.sciencedirect.com/science/article/pii/S0965229925000809
💥 https://www.liebertpub.com/doi/abs/10.1177/27683605251377417
💥 https://journals.sagepub.com/doi/10.1177/20503245251362491
percent to 8.1 percent fewer opioid prescriptions.” ⬇️
💥 https://www.marijuanamoment.net/legalizing-medical-marijuana-leads-to-significant-reductions-in-opioid-prescriptions-another-study-shows/
💥 https://www.congress.gov/bill/119th-congress/house-bill/5068/cosponsors 🚀
💥 https://www.sciencedirect.com/science/article/pii/S0965229925000809
💥 https://www.liebertpub.com/doi/abs/10.1177/27683605251377417
💥 https://journals.sagepub.com/doi/10.1177/20503245251362491
Bullish
Recent CVSI News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/10/2026 08:04:10 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/26/2026 09:14:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/26/2026 08:06:03 PM
- CV Sciences, Inc. Reports Fiscal Year-End 2025 Financial Results • ACCESS Newswire • 03/26/2026 08:00:00 PM
- CV Sciences, Inc. To Announce Year End and Fourth Quarter 2025 Results On March 26, 2026 • ACCESS Newswire • 03/24/2026 09:00:00 PM
- CV Sciences Announces Successful Debt Restructuring Designed to Strengthen Financial Position and Fuel Future Growth • ACCESS Newswire • 03/10/2026 09:00:00 PM
- CV Sciences Launches EMPOWR: A Plant-Based Protein + Creatine Formula Designed for Total Wellness • ACCESS Newswire • 02/26/2026 01:30:00 PM
- CV Sciences, Inc. Positioned to Participate in the Medicare and Medicaid Pilot Program for CBD • ACCESS Newswire • 12/23/2025 12:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2025 10:19:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2025 09:04:08 PM
- CV Sciences, Inc. Reports Third Quarter 2025 Financial Results • ACCESS Newswire • 11/13/2025 09:00:00 PM
- CV Sciences, Inc. to Announce Third Quarter 2025 Results on November 13, 2025 • ACCESS Newswire • 11/10/2025 11:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2025 09:05:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2025 08:24:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2025 09:23:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2025 08:01:09 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2025 08:50:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2025 08:01:33 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/15/2025 09:25:41 PM
